Human vaccines & immunotherapeutics.

ISSN 2164-5515Taylor and Francis Ltd.United States
ScopusMEDLINEEmbasePubMedPMCSCImagoDOAJJIFMatched via identifier

Journal overview

Journal identity
Titles
Human Vaccines and Immunotherapeutics
Hum. Vaccines Immunother. (abbreviated)
Human Vaccines & Immunotherapeutics
Hum Vaccin Immunother (abbreviated)
Human Vaccines & Immunotherapeutics TAYLOR & FRANCIS INC
Human vaccines & immunotherapeutics.
Key identifiers
ISSN
2164-5515
2164-5515
eISSN
2164-554X
NLM ID
101572652
Publisher / basic metadata
Publisher
Taylor and Francis Ltd.
Taylor & Francis
Austin, Tex. : Landes Bioscience
Country
Language
ENG
English

Indexing & coverage

Current indexing summary
Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2012–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCCoverage available

Metrics

MetricYearValueQuartileRankSource
JIF20253.5Q23784JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
1.094
Best Quartile
Q1
H-index
113
Subject categories (quartile varies by category)
  • Medicine (miscellaneous) — Q1
  • Pharmacology — Q1
  • Immunology — Q2
  • Immunology and Allergy — Q2
More metrics
Coverage
2012–2026
Country
United States
Region
Northern America
Publisher
Taylor and Francis Ltd.
Open Access
Yes
Open Access (Diamond)
No
Total documents (current year)
553
Total documents (3 years)
1711
Total references
27829
Total citations (3 years)
6307
Citable documents (3 years)
1475
Citations per document (2 years)
3.68
References per document
50.32
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
2164-5515, 2164-554X
SCImago Source ID
21100200427
SCImago Rank (across all SCImago source types)
4225

Publication activity

Publication activity
SCImago
2025
553 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Open access

DOAJ — Directory of Open Access Journals

Source: DOAJ (Directory of Open Access Journals). Listing status and policy details are reported here as DOAJ published them.

Listed in DOAJ
Yes
License
CC BY, CC BY-NC
APC (article processing charge)
5085 AUD; 3505 EUR; 2920 GBP; 3650 USD
More information
Waiver policy
Yes
Review process
Anonymous peer review
Plagiarism screening
Yes
Preservation services
CLOCKSS, LOCKSS, PMC, Portico
Added to DOAJ
2022-07-18
Journal homepage
DOAJ profile
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
2164-5515, 2164-554X

Subjects & categories

Subjects / categories
Subject area (SCImago)
MeSH (PubMed)
Immunotherapy; Vaccines
Coverage / history
Scopus:2012-2026
MEDLINE:MEDLINE: v8n1, Jan. 2012-In: PubMed: v8n1, Jan. 2012-, PMC;
PubMed:MEDLINE: v8n1, Jan. 2012-In: PubMed: v8n1, Jan. 2012-, PMC;
PMC:v.8(1) 2012 – v.22(1) 2026